...
首页> 外文期刊>The journal of gene medicine >A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population
【24h】

A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population

机译:超氧化物歧化酶基因多态性与抗核酸药物诱导的中国汉族人群肝损伤的前瞻性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Antituberculosis drug-induced liver injury (ATDILI) is increasing globally and, hence, it is crucial to predict its risk in the clinical management of antituberculosis therapy. As a major antioxidant, superoxide dismutase (SOD) is mainly responsible for providing defence against oxidative stress, which is involved in ATDILI. The present study aimed to investigate the associations between polymorphisms in SOD genes, including Cu/ZnSOD (SOD1), mitochondrial manganese SOD (MnSOD or SOD2) and extracellular SOD (SOD3), as well as the susceptibility to ATDILI in a Chinese Han population. Methods In total, 1060 Chinese Han subjects highly suspected to have tuberculosis (TB) were prospectively enrolled from West China Hospital of Sichuan University. Overall, 746 subjects comprising 118 ATDILI and 628 ATD-tolerant TB patients were eligible and were genotyped for seven single-nucleotide polymorphisms in three SOD genes (SOD1: rs4816407 and rs1041740; SOD2: rs4880; SOD3: rs699473, rs2536512, rs2855262 and rs8192290). Results Logistic regression analysis showed that none of the seven genetic variants in the three SOD genes were significantly associated with susceptibility to ATDILI in the Chinese Han population after Bonferroni correction, except for a potential association for the SOD2 rs4880 A>G (G allele, p = 0.190, odds ratio = 1.53, 95% confidence interval = 1.05-2.23; GG genotype, p = 0.155). Conclusions The promising application of single-nucleotide polymorphisms in the SOD1, SOD2 and SOD3 genes as genetic markers for ATDILI is challenged, and further studies are needed with larger sample sizes and different ethnicities, especially for SOD2 rs4880.
机译:背景技术抗结核诱导药物诱导的肝损伤(ATDILI)在全球范围内越来越大,因此,预测其在抗尿嘧啶疗法临床管理中的风险至关重要。作为主要的抗氧化剂,超氧化物歧化酶(SOD)主要负责为涉及ATDILI的氧化应激提供防御。本研究旨在研究SOD基因多态性的关联,包括Cu / ZnSOD(SOD1),线粒体锰SOD(MNSOD或SOD2)和细胞外草皮(SOD3),以及在中国汉族人群中对Atdili的敏感性。总共有1060例中国汉族受试者的方法,高度涉嫌患有结核病(TB),从四川大学西部医院前瞻性地注册。总体而言,包含118个atdili和628个耐受性TB患者的746名受试者符合条件,并在三种SOD基因中进行七种单核苷酸多态性的基因分型(SOD1:RS4816407和RS1041740; SOD2:RS4880; SOD3:RS699473,RS2855262和RS8192290) 。结果逻辑回归分析表明,三种SOD基因中的七种遗传变异都没有与Bonferroni校正后中国汉族人群的易感性显着相关,除了SOD2 RS4880 A> G(G等位基因,P = 0.190,差距= 1.53,95%置信区间= 1.05-2.23; GG基因型,P = 0.155)。结论作为atdili遗传标记的SOD1,SOD2和SOD3基因中单核苷酸多态性的有望应用受到挑战,需要进行更大的样本尺寸和不同种族的进一步研究,特别适用于SOD2 RS4880。

著录项

  • 来源
    《The journal of gene medicine》 |2019年第10期|共9页
  • 作者单位

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

    Pulm Hosp Lanzhou Dept Lab Med Lanzhou Gansu Peoples R China;

    Sichuan Univ West China Hosp Dept Lab Med Chengdu Sichuan Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

    antituberculosis drugs; liver injury; polymorphisms; superoxide dismutase;

    机译:抗结核药物;肝损伤;多态性;超氧化物歧化酶;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号